Janney Montgomery Scott LLC Processa Pharmaceuticals, Inc. Transaction History

Janney Montgomery Scott LLC

  • $35.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 29, 2021
SELL
$5.28 - $8.61 $55,440 - $90,405
-10,500 Reduced 18.51%
46,231 $396,000
Q2 2021

Jul 26, 2021
SELL
$6.15 - $10.95 $40,590 - $72,270
-6,600 Reduced 10.42%
56,731 $465,000
Q1 2021

Apr 27, 2021
SELL
$5.96 - $13.15 $17,880 - $39,450
-3,000 Reduced 4.52%
63,331 $690,000
Q4 2020

Jan 25, 2021
BUY
$3.95 - $8.48 $262,007 - $562,486
66,331 New
66,331 $437,000

About Processa Pharmaceuticals, Inc.

PCSA Quotes by TradingView
  • Ticker PCSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,856,200
  • Market Cap $14.6M
  • Description
  • Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...
More about PCSA
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email